ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.65
0.48%
US Tech 100
18,318.00
0.95%
S&P 500
5,304.72
0.70%
US Dollar vs CAD
1.36775
0.00%
Bitcoin
68,642.81
0.16%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) News

PRTC

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
05/23/20246:00AMBusiness WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
05/21/20246:05AMBusiness WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
05/20/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
05/20/20246:03AMEdgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
05/20/20241:00AMBusiness WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
05/09/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
05/07/20246:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
04/25/20244:22AMBusiness WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
04/18/20241:00AMBusiness WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
04/16/20246:00AMBusiness WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
04/11/20246:00AMBusiness WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
04/09/20241:00AMBusiness WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
03/19/20242:00AMBusiness WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
03/18/20248:52AMBusiness WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
03/13/20246:00AMBusiness WirePureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
02/27/20246:00AMBusiness WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
02/27/20241:00AMBusiness WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:PRTCPureTech Health PLC
01/04/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
01/03/20246:00AMBusiness WirePureTech to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
12/22/20238:13AMBusiness WirePureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 BillionNASDAQ:PRTCPureTech Health PLC
12/20/20231:00AMBusiness WirePureTech Year End Update and Outlook for 2024NASDAQ:PRTCPureTech Health PLC
12/07/20235:00AMBusiness WirePureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023NASDAQ:PRTCPureTech Health PLC
11/29/20239:17AMBusiness WirePureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of SchizophreniaNASDAQ:PRTCPureTech Health PLC
11/17/20231:00AMBusiness WirePureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNASDAQ:PRTCPureTech Health PLC
11/14/20231:00AMBusiness WirePureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersNASDAQ:PRTCPureTech Health PLC
11/02/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
10/17/20231:00AMBusiness WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
10/11/20236:00AMBusiness WirePureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual MeetingNASDAQ:PRTCPureTech Health PLC
10/04/20236:05AMBusiness WirePureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track DesignationNASDAQ:PRTCPureTech Health PLC
09/28/20236:38AMBusiness WireKarXT, invented at PureTech, submitted for FDA Approval in SchizophreniaNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC

Your Recent History

LSE
CIHL
Caribbean Investment
COIN
CRTTTTEUR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved